StonvexLoading…
StonvexStonvexStonvexCore line items from DOLE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $2.34B | $9.17B | $2.10B | $8.48B |
Operating Income | $61.96M | $222.97M | $67.91M | $280.56M |
Net Income | $31.30M | $51.32M | $38.91M | $125.51M |
EPS (Diluted) | $0.33 | $0.53 | $0.41 | $1.32 |
Total Assets | $4.45B | $4.40B | Not available | $4.45B |
Total Liabilities | $2.93B | $2.89B | Not available | $3.01B |
Cash & Equivalents | $273.17M | $267.85M | $256.52M | $330.02M |
Free Cash Flow OCF − CapEx | $-40.23M | $1.71M | $-131.63M | $180.29M |
Shares Outstanding | 95.16M | 95.16M | 95.68M | 95.04M |